OrthoGold 350

OrthoGold 350

Description

Device Overview

The SoftWave OrthoGold 350 is a premium electrohydraulic extracorporeal shockwave therapy (ESWT) system designed to stimulate the body's natural healing processes using patented broad-focused acoustic shockwave technology.

Unlike conventional radial pressure wave devices or focused shockwave systems, the OrthoGold 350 utilizes an electrohydraulic spark-gap generator and a patented parabolic reflector to produce a true broad-focused shockwave. This design distributes energy across a much larger treatment field, allowing simultaneous treatment of superficial and deep tissues while minimizing patient discomfort.

Key Attributes

True Electrohydraulic Shockwave Technology

True ESWT (Extracorporeal Shockwave Therapy)

Electrohydraulic spark-gap energy source

Patented broad-focused energy delivery

Parallel acoustic wave propagation

Non-invasive treatment


Unlike pneumatic radial devices, the OrthoGold produces a true acoustic shockwave capable of deeper tissue penetration and broader biological activation.


Broad Treatment Zone

One of the largest treatment fields available.

Approximate treatment area:

7 cm × 12 cm

Simultaneous superficial and deep tissue activation

Less need to reposition the applicator

Faster treatment sessions


This larger treatment zone is a defining feature of the SoftWave platform.


Portable Clinical System

Compact console

Touchscreen interface

Portable carrying case

Handheld applicator

Quick setup

Standard 100–240 VAC power


Ideal for:

Orthopedic clinics

Sports medicine

Physical therapy

Chiropractic offices

Regenerative medicine practices

Mobile treatment providers


Patient-Friendly Treatment

No anesthesia required

No injections

Drug-free

Non-surgical

Minimal downtime

Typical treatment time of 10–15 minutes


Designed for outpatient clinical use.


Mechanism of Action

The OrthoGold 350 delivers high-energy acoustic shockwaves into injured tissue, where mechanical energy is converted into biological responses that promote healing.

Potential physiologic effects include:

Increased local blood circulation

Activation of connective tissue

Cellular signaling

Stimulation of angiogenesis

Reduction of inflammation

Tissue remodeling

Pain reduction

Promotion of tendon and ligament healing


These effects are the basis for its use across orthopedic, wound care, and regenerative medicine applications.


Clinical Applications

Orthopedics

Treatment of chronic and acute musculoskeletal disorders, including:

Rotator cuff injuries

Shoulder impingement

Calcific tendonitis

Frozen shoulder

Tennis elbow

Golfer's elbow

Biceps tendinitis

Hip pain

Trochanteric bursitis

IT band syndrome

Patellar tendinitis

Quadriceps injuries

Hamstring injuries

Achilles tendinopathy

Plantar fasciitis

Heel spurs

Shin splints

Stress fractures (adjunctive treatment)

Chronic joint pain

Sports Medicine

Commonly used for:

Muscle strains

Ligament injuries

Tendon injuries

Overuse syndromes

Return-to-play rehabilitation

Chronic athletic injuries

Soft tissue regeneration


Physical Therapy

Used during rehabilitation for:

Chronic pain

Scar tissue remodeling

Tendon healing

Range-of-motion improvement

Myofascial restrictions

Post-operative rehabilitation

Chiropractic

Common treatments include:

Cervical pain

Thoracic pain

Lumbar pain

Trigger points

Muscle spasms

Fascial restrictions

Chronic inflammation


Podiatry

Frequently used for:

Plantar fasciitis

Heel spurs

Achilles tendon disorders

Chronic foot pain

Diabetic foot ulcers

Regenerative Medicine

Often incorporated with biologic therapies such as:

Platelet-Rich Plasma (PRP)

Bone marrow concentrate

Stem cell-based procedures

Exosome therapy

Prolotherapy


The shockwave treatment is intended to enhance the tissue healing environment and improve local biologic activity. (The use of biologic therapies depends on clinician judgment and regulatory requirements.)



Wound Care

The OW100S-US platform has FDA clearances for:

Chronic diabetic foot ulcers

Superficial partial-thickness second-degree burns


These indications are used in conjunction with standard wound or burn care.


FDA-Cleared Uses (United States)

The OW100S-US is FDA cleared for:

Temporary relief of minor muscle aches and pains

Temporary increase in local blood circulation

Activation of connective tissue

Treatment of chronic diabetic foot ulcers

Treatment of superficial partial-thickness second-degree burns


Specifications

ManufacturerMTS Medical UG
ModelOW100S-US
Year2023
ConditionUsed
Serial NumberOW100S-US
Stock NumberOW100S-US